FDA Inspection 807328 — Dottikon Exclusive Synthesis AG
The FDA completed an inspection of Dottikon Exclusive Synthesis AG on September 28, 2012 in Dottikon. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 28, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dottikon (Switzerland)